Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_3

71%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

5(83.3%)

Phase 4Post-market surveillance

1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Other(1)

Detailed Status

Completed5

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Phase 35 (83.3%)

Phase 41 (16.7%)

Trials by Status

completed571%

terminated114%

unknown114%

Recent Activity

0 active trials

Showing 5 of 7

completed

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital

NCT00320957

completedphase_3

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital

NCT00320762

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT00477685

Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India

Completed

NCT00448929Phase 3

Ologen (OculusGen)-Glaucoma Case Control Trial in India

Completed

NCT00449098Phase 4

Ologen (OculusGen)-Glaucoma MMC Control Trial in India

Unknown

NCT00320957Phase 3

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital

Completed

NCT00320762Phase 3

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital

Completed

NCT00321035Phase 3

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital

Completed

NCT00406822Phase 3

OculusGen-Glaucoma Historical Control Study in Taiwan

Terminated

All 7 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 7